Yoshiya Yamada, MD, Radiation Oncologist at Memorial Sloan Kettering Cancer Center in New York City discusses radiosurgery (SRS) versus conventional fractionated radiotherapy for spinal and bone metastases. He begins by discussing histologic classification in terms of radiosensitivity and radioresistance and how that applies to spinal metastases before giving an overview of the results of several related studies.
